Vivos Therapeutics, Inc. (VVOS)
0.0569
-0.02
(-25.13%)
USD |
NASDAQ |
Nov 19, 16:00
0.0567
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Enterprise Value : 11.72M for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 11.72M |
| November 17, 2026 | 11.85M |
| November 16, 2026 | 11.93M |
| November 13, 2026 | 12.46M |
| November 12, 2026 | 12.39M |
| November 11, 2026 | 12.21M |
| November 10, 2026 | 12.07M |
| November 09, 2026 | 12.39M |
| November 06, 2026 | 12.32M |
| November 05, 2026 | 12.62M |
| November 04, 2026 | 12.91M |
| November 03, 2026 | 12.86M |
| November 02, 2026 | 12.81M |
| October 30, 2026 | 13.00M |
| October 29, 2026 | 13.23M |
| October 28, 2026 | 13.27M |
| October 27, 2026 | 13.49M |
| October 26, 2026 | 13.59M |
| October 23, 2026 | 13.67M |
| October 22, 2026 | 13.63M |
| October 21, 2026 | 13.71M |
| October 20, 2026 | 13.91M |
| October 19, 2026 | 13.71M |
| October 16, 2026 | 13.58M |
| October 15, 2026 | 13.98M |
| Date | Value |
|---|---|
| October 14, 2026 | 13.68M |
| October 13, 2026 | 13.94M |
| October 12, 2026 | 14.03M |
| October 09, 2026 | 14.19M |
| October 08, 2026 | 14.21M |
| October 07, 2026 | 14.26M |
| October 06, 2026 | 14.35M |
| October 05, 2026 | 14.36M |
| October 02, 2026 | 14.28M |
| October 01, 2026 | 14.19M |
| September 30, 2026 | 14.15M |
| September 29, 2026 | 13.85M |
| September 28, 2026 | 13.61M |
| September 25, 2026 | 13.71M |
| September 24, 2026 | 13.78M |
| September 23, 2026 | 13.83M |
| September 22, 2026 | 13.94M |
| September 21, 2026 | 13.99M |
| September 18, 2026 | 14.04M |
| September 17, 2026 | 14.22M |
| September 16, 2026 | 14.01M |
| September 15, 2026 | 14.04M |
| September 14, 2026 | 14.23M |
| September 11, 2026 | 14.34M |
| September 10, 2026 | 14.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Hinge Health, Inc. | 9.041B |
| Exlites Holdings International, Inc. | 15.42M |
| Xcelerate, Inc. | 9.806M |
| Abbott Laboratories | 208.41B |
| AngioDynamics, Inc. | 457.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.971M |
| Revenue (Quarterly) | 6.414M |
| Total Expenses (Quarterly) | 8.359M |
| EPS Diluted (Quarterly) | -0.0733 |
| Gross Profit Margin (Quarterly) | 43.09% |
| Profit Margin (Quarterly) | -30.73% |
| Earnings Yield | -2.90K% |
| Normalized Earnings Yield | -2935.68 |